Vardenafil Hydrochloride Tablet
Product Images NDC 72162-2235

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Vardenafil Hydrochloride (NDC 72162-2235). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622235)

Label for Vardenafil Hydrochloride Tablets 10 mg oral tablets. The label includes NDC 72162-2235-3, a package size of 30 tablets, and indicates the product is Rx only. The labeler is Bryant Ranch Prepack, and the manufacturer is Rivopharm SA. Additional storage and usage instructions are partially visible.*

FDA Label Image

Chemical Structure (Vardenafil Figure 1)

Chemical structure of Vardenafil Hydrochloride, showing its molecular framework including ring systems and functional groups, along with notation indicating association with hydrochloride and trihydrate components.*

FDA Label Image

Figure 1 (Vardenafil Figure 2)

The image contains three line graphs displaying the mean maximal change in systolic blood pressure (mmHg), diastolic blood pressure (mmHg), and heart rate (bpm) over time before Nitroglycerin (Pre-NTG) treatment with Vardenafil. Each graph plots changes at 24 hours, 8 hours, 4 hours, and 1 hour intervals, showing trends in cardiovascular parameters related to Vardenafil treatment timing.*

FDA Label Image

Figure 2 (Vardenafil Figure 3)

A line graph displaying mean change in mmHg (y-axis) over time in hours (x-axis) for Vardenafil 5 mg and placebo under simultaneous and 6-hour separation conditions. Four data series are plotted: placebo simultaneous, placebo 6-hr separation, Vardenafil 5 mg simultaneous, and Vardenafil 5 mg 6-hr separation, showing different trends in blood pressure changes over a 6-hour period.*

FDA Label Image

Figure 3 (Vardenafil Figure 4)

A line graph showing mean change (mmHg) over time (hours) comparing placebo and Vardenafil 5 mg under simultaneous and 6-hour separation conditions. The graph plots four data sets: placebo (simultaneous and 6 hr separation) and Vardenafil 5 mg (simultaneous and 6 hr separation), illustrating changes in blood pressure over a 6-hour period.*

FDA Label Image

Figure 4 (Vardenafil Figure 5)

A line graph showing mean change in mmHg over time (hours) for Vardenafil 10 mg and 20 mg compared to placebo across two stages. The x-axis represents time in hours (0 to 6), and the y-axis shows mean change in mmHg from -10 to 5. Data lines include solid and dashed styles with different markers representing each group and stage.*

FDA Label Image

Figure 5 (Vardenafil Figure 6)

A line graph depicting mean change in mmHg over 6 hours for multiple groups including Placebo (Stages 1 and 2) and Vardenafil at 5 mg and 10 mg doses. The x-axis represents time in hours, while the y-axis shows mean change in blood pressure in mmHg, illustrating the variations in response over time.*

FDA Label Image

Figure 6 (Vardenafil Figure 7)

A line graph titled "TERAZOSIN" showing mean change in mmHg over time (0 to 6 hours) for placebo, 10 mg vardenafil, and 20 mg vardenafil under two conditions: 6-hour separation and simultaneous administration. The graph compares blood pressure changes across these groups with distinct line and marker styles for each condition and dosage.*

FDA Label Image

Figure 7 (Vardenafil Figure 8)

A line graph depicting mean change in blood pressure (mmHg) over time (hours) for different conditions involving Tamsulosin and Vardenafil. The lines represent placebo and Vardenafil at 10 mg and 20 mg doses, administered either with 6-hour separation or simultaneously, showing varying blood pressure responses up to 6 hours.*

FDA Label Image

Figure 8 (Vardenafil Figure 9)

A line graph showing plasma concentration (µg/L) over time (hours) for Vardenafil Hydrochloride. The plasma concentration peaks around 1 hour and then gradually declines to near zero by 24 hours, with error bars indicating variability at each time point.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.